You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) — CareFirst BlueCross BlueShield has struck a deal to evaluate the clinical impact of Exagen Diagnostics' Avise Lupus test for the differential diagnosis of systemic lupus erythematosus (SLE), the companies announced today.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.